High diagnostic yield of clinical exome sequencing in Middle
Tarunashree Yavarna(Hamad Medical Corporation), Tawfeg Ben‐Omran(Qatar Airways (Qatar)), Patrik Vitazka(Inserm), Mariam Al‐Mureikhi(Hamad Medical Corporation), Shenela Lakhani(Hamad Medical Corporation), Fatma Al‐Mesaifri(Hamad Medical Corporation), Nader Al‐Dewik(St George's, University of London), Noora Shahbeck(Hamad Medical Corporation), Mariam AlMulla(Hamad Medical Corporation), Fowzan S. Alkuraya(Alfaisal University), Laila Mahmoud(Hamad Medical Corporation), Rehab Ali(Hamad Medical Corporation), Zafar Nawaz(University of Miami)
Unknown
January 1, 2015
Cited by 0
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636